Bulletin
Investor Alert

Dynavax Technologies Corp.

NAS: DVAX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 27, 2022, 7:55 p.m.

/zigman2/quotes/203017054/composite

$

12.00

Change

-0.43 -3.46%

Volume

Volume 59,783

Quotes are delayed by 20 min

/zigman2/quotes/203017054/composite

Previous close

$ 11.68

$ 12.43

Change

+0.75 +6.42%

Day low

Day high

$11.57

$12.46

Open

52 week low

52 week high

$7.26

$21.39

Open

Insider Actions for Dynavax Technologies Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/17/2022 Justin Burgess
Principal Accounting Officer
6,000   Disposition at $10 per share. 60,000
05/16/2022 Justin Burgess
Principal Accounting Officer
6,000   Derivative/Non-derivative trans. at $0 per share. 0
03/03/2022 Ryan Spencer
CEO and Director; Director
52,835   Disposition at $10.56 per share. 557,937
03/03/2022 Ryan Spencer
CEO and Director; Director
17,611   Disposition at $10.57 per share. 186,148
03/03/2022 Ryan Spencer
CEO and Director; Director
12,662   Disposition at $10.57 per share. 133,837
03/03/2022 David F. Novack
President & COO
31,079   Disposition at $10.57 per share. 328,505
03/03/2022 David F. Novack
President & COO
10,783   Disposition at $10.57 per share. 113,976
03/03/2022 Robert Janssen
Senior Vice President
17,760   Disposition at $10.57 per share. 187,723
03/03/2022 Robert Janssen
Senior Vice President
6,276   Disposition at $10.56 per share. 66,274
03/03/2022 Justin Burgess
Principal Accounting Officer
6,000   Disposition at $10.58 per share. 63,480
03/03/2022 Justin Burgess
Principal Accounting Officer
3,167   Disposition at $10.58 per share. 33,506
03/03/2022 Justin Burgess
Principal Accounting Officer
8,417   Disposition at $10.58 per share. 89,051
03/03/2022 Justin Burgess
Principal Accounting Officer
3,906   Disposition at $10.58 per share. 41,325
03/02/2022 Ryan Spencer
CEO and Director; Director
29,750   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Ryan Spencer
CEO and Director; Director
20,833   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 David F. Novack
President & COO
17,500   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Robert Janssen
Senior Vice President
10,000   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Justin Burgess
Principal Accounting Officer
6,000   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Justin Burgess
Principal Accounting Officer
3,167   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Justin Burgess
Principal Accounting Officer
8,417   Derivative/Non-derivative trans. at $0 per share. 0
03/02/2022 Justin Burgess
Principal Accounting Officer
3,906   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2022 Ryan Spencer
CEO and Director; Director
1,457   Award at $10.29 per share. 14,992
02/15/2022 David F. Novack
President & COO
1,009   Award at $10.29 per share. 10,382
02/15/2022 Robert Janssen
Senior Vice President
467   Award at $10.29 per share. 4,805
02/15/2022 Justin Burgess
Principal Accounting Officer
133   Award at $10.29 per share. 1,368
02/10/2022 Ryan Spencer
CEO and Director; Director
89,250   Derivative/Non-derivative trans. at $0 per share. 0
02/10/2022 David F. Novack
President & COO
52,500   Derivative/Non-derivative trans. at $0 per share. 0
02/10/2022 Robert Janssen
Senior Vice President
30,000   Derivative/Non-derivative trans. at $0 per share. 0
11/17/2021 Robert Janssen
Senior Vice President
53,431   Disposition at $17.07 per share. 912,067
11/17/2021 Robert Janssen
Senior Vice President
53,431   Derivative/Non-derivative trans. at $10.47 per share. 559,422
11/16/2021 Robert Janssen
Senior Vice President
35,974   Disposition at $17.16 per share. 617,313
11/16/2021 Robert Janssen
Senior Vice President
35,974   Derivative/Non-derivative trans. at $10.47 per share. 376,647
11/01/2021 David F. Novack
President & COO
20,000   Disposition at $20.12 per share. 402,400
10/07/2021 David F. Novack
President & COO
3,000   Disposition at $18 per share. 54,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
9 Purchases
12 Sales
105,573
176,496
Last 6 months
16 Purchases
12 Sales
280,389
176,496
Last 12 months
28 Purchases
24 Sales
2,334,178
2,464,169

Officers and Executives

Mr. Scott D. Myers
Chairman
Mr. David F. Novack
President & Chief Operating Officer
Mr. Ryan Spencer
Chief Executive Officer & Director
Ms. Kelly MacDonald
Chief Financial Officer & Senior Vice President
Dr. Patricia Novy
Vice President-Medical Affairs
Mr. Todd Lopeman
Vice President-Technical Operations
Dr. Robert Janssen
Chief Medical Officer & SVP-Clinical Development
Dr. Dong Yu
Senior Vice President-Vaccine Research
Dr. Riccardo Manetti
Vice President-Business Development
Mr. Alex Oh
Vice President-Intellectual Property
Ms. Meg Smith
Vice President-Sales & Operations
Mr. Justin Burgess
Principal Accounting Officer & Controller
Ms. Nicole Arndt
Senior Manager-Investor Relations
Mr. Jeff P. Coon
Senior VP-Human Resources & Corporate Services
Mr. John L. Slebir
Senior Vice President & General Counsel
Dr. Andrew A. F. Hack
Independent Director
Mr. Brent MacGregor
Independent Director
Dr. Peter R. Paradiso
Independent Director
Ms. Julia Marie Eastland
Independent Director
Ms. Elaine D. Sun
Independent Director
Dr. Francis R. Cano
Independent Director
Dr. Daniel L. Kisner
Independent Director
Mr. Natale S. Ricciardi
Independent Director
Ms. Peggy V. Phillips
Independent Director
Link to MarketWatch's Slice.